Trial Profile
A observational study investigating the effect of Bevacizumab plus chemotherapy in metastatic colorectal cancer patients from Germany
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Roche
- 26 Nov 2015 New trial record